Merck Sharpe and Dohme Company Profile

05:54 EDT 24th March 2018 | BioPortfolio

News Articles [773 Associated News Articles listed on BioPortfolio]

MSD's new research centre a big boost for Brexit Britain

Merck, Sharp, and Dohme (MSD) has announced it is to build a state of the art life sciences R&D facility in London, creating around 950 jobs. Known as Merck & Co in the US, the company said t...

After 5 Years And 2 Clinical Trials, Patient #1 Stops Cancer Treatment |  T.J. Sharpe, who shared his fight with Stage 4 Melanoma in the "Patient #1" blog, has recently decided to stop taking Merck's anti-PD-1 drug for treatment.    

Trastuzumab biosimilar Ontruzant launched in the UK

Merck Sharp and Dohme (MSD), which is known as Merck in the US and Canada, announced on 8 March 2018 that it had launched the trastuzumab biosimilar, Ontruzant, in the UK.

MSD repurposing dormant Irish site and hiring 350 to support Keytruda

Merck Sharp & Dohme (MSD) plans to build a biologics facility at a former small molecule manufacturing site in Swords, Ireland, which it closed last year.

MSD, Wayra UK launch third Velocity Health programme

Merck Sharp & Dohme and Telefonica's Wayra UK have unveiled the next focus of their digital health innovation accelerator programme, calling on tech start-ups to "re-imagine healthcare" with the h...

MSD and Wayra to fund UK digital health start-ups

Big pharma company Merck Sharp & Dohme is teaming up with Wayra UK to offer more start-up funds for new digital health companies in the UK. MSD has been working with Wayra UK (part of Spanish tel...

Pharma Q3 Results Preview: Merck & Co., Merck KGaA

Investors will be eager to hear updates on Merck & Co.'s Keytruda market share versus other PD-1/L1 competitors in lung...   

Crack Open the Champagne, AiCuris’ Antiviral Gets FDA Approval

AiCuris will be jumping for joy after its Human Cytomegalovirus (HCMV) treatment, letermovir, was approved by the FDA. AiCuris develops antiviral and antibacterial agents to treat life-threatening ...

Drugs and Medications [63 Associated Drugs and Medications listed on BioPortfolio]

Aminohippurate sodium [Merck Sharp & Dohme Corp.]


Januvia [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) TabletsInitial U.S. Approval: 20...

Fosamax plus d [Merck Sharp & Dohme Corp.]

These highlights do not include all the information needed to use FOSAMAX PLUS D safely and effectively. See full prescribing information for FOSAMAX PLUS D. FOSAMAX PLUS D(alendronate sodium/cholecal...

A and d original [MSD Consumer Care, Inc.]

A+D Prevent Original Ointment

Primaxin [Merck Sharp & Dohme Corp.]


PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Treating MS without continuous immunosuppression: an interview with Luciano Rossetti.

Luciano Rossetti, MD, Executive Vice President, Global Head of R&D at Merck KGaA, Darmstadt, Germany speaks to Laura Dormer, Commissioning Editor Luciano Rossetti, MD, is Executive Vice President, Glo...

The Recipe for Corporate Longevity: From the Perspective of "Managing Innovation".

The elephant is in the room-a metaphorical idiom for an obvious problem or risk that nobody wants to discuss. This abstract is not intended to be a summary, to reveal major findings, or unveil conclus...

Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling.

Merck & Co., Inc. (Kenilworth, New Jersey) has recently published an integrated strategy for implementation of dried blood spots (DBS) in late-stage trials for population pharmacokinetic (PK) modeling...

CHEMGENIE: integration of chemogenomics data for applications in chemical biology.

Increasing amounts of biological data are accumulating in the pharmaceutical industry and academic institutions. However, data do not equal actionable information, and guidelines for appropriate data ...

Genomic insights into the non-histamine production and proteolytic and lipolytic activities of Tetragenococcus halophilus KUD23.

Tetragenococcus halophilus KUD23, a non-histamine producer, was isolated from a traditional Korean high-salt fermented soybean paste, doenjang. The strain was safe in terms of antibiotic susceptibilit...

Clinical Trials [84 Associated Clinical Trials listed on BioPortfolio]

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

To demonstrate bioequivalence of single dose test formulation of Losartan potassium tablets (containing Losartan potassium 100 mg) of Pharmtechnology LLC, Republic of Belarus with referenc...

To Demonstrate the Relative Bioavailability of Cyclobenzaprine HCl Tablets

To demonstrate the relative bioavailability of Cyclobenzaprine HCl tablets.

Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

The objective of this study is to compare the rate and extent of absorption of alendronate sodium 70 mg tablets (test) versus Fosamax® 70 mg tablets (reference) administered as a single d...

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

The present study was a randomized, open-label, two-period, two-sequence, cross-over study, conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa Medic...

Companies [137 Associated Companies listed on BioPortfolio]

Merck Sharpe and Dohme

Merck and Cardiome Pharma Corp.

In April 2009, Cardiome and Merck announced a collaboration and license agreement for the development and commercialization of vernakalant. The agreement provides Merck, Sharp and...

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

More Information about "Merck Sharpe and Dohme" on BioPortfolio

We have published hundreds of Merck Sharpe and Dohme news stories on BioPortfolio along with dozens of Merck Sharpe and Dohme Clinical Trials and PubMed Articles about Merck Sharpe and Dohme for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck Sharpe and Dohme Companies in our database. You can also find out about relevant Merck Sharpe and Dohme Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record